NCT05778981 Endothelial Dysfunction and Non-cardiac Surgery
| NCT ID | NCT05778981 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chile |
| Condition | Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-03-25 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-03-25 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endothelial dysfunction is a cardiovascular disease hallmark. After non-cardiac surgery, cardiovascular events correlate with surgical outcomes. Understanding the role of endothelial function in these events is crucial. This research aims to study endothelial function and its association with cardiovascular events.
Eligibility Criteria
Inclusion Criteria: * Signed informed consent * Patients 45 years or older Exclusion Criteria: * Refuse to participate in the study * Myocardial injury or acute myocardial infarction less than two weeks ago * Patients who expect less than 2 days of hospitalization * Patients in whom the troponin elevation is attributed to a secondary cause (for example, sepsis, pulmonary thromboembolism, electrical cardioversion, etc.) * Use of chemotherapy less than 2 weeks ago
Contact & Investigator
Felipe Maldonado||, M.D.,M.Sc.
STUDY CHAIR
Hospital Clinico de la Universidad de Chile
Frequently Asked Questions
Who can join the NCT05778981 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05778981 currently recruiting?
Yes, NCT05778981 is actively recruiting participants. Contact the research team at fmaldonado@uchile.cl for enrollment information.
Where is the NCT05778981 trial being conducted?
This trial is being conducted at Independencia, Chile.
Who is sponsoring the NCT05778981 clinical trial?
NCT05778981 is sponsored by University of Chile. The principal investigator is Felipe Maldonado||, M.D.,M.Sc. at Hospital Clinico de la Universidad de Chile. The trial plans to enroll 200 participants.